Pharmacological approaches to cardio-renal syndrome: a role for the inodilator levosimendan
Clicks: 117
ID: 274425
2017
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
0.6
/100
2 views
2 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Pathological interplay between the heart and kidneys—also known as cardio-renal syndrome (CRS)—is frequently encountered in heart failure and is linked to worse prognosis and quality of life. Drug therapies for this complex situation may ...
| Reference Key |
matskeplishvili2017europeanpharmacological
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Francesco Fedele, Kristjan Karason, Simon Matskeplishvili;Francesco Fedele;Kristjan Karason;Simon Matskeplishvili; |
| Journal | European heart journal supplements : journal of the European Society of Cardiology |
| Year | 2017 |
| DOI | 10.1093/eurheartj/sux002 |
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.